Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were ... them that patients with Type 1 diabetes need ...
Insulin lispro, the rapid-acting component of Humalog Mix75/25, has been shown to be equipotent to Regular human insulin on a molar basis. Instruct patients on diet, exercise, blood or urine ...
The primary activity of insulin including Humalog Mix50/50 is the regulation of glucose metabolism. Insulins lower blood glucose by stimulating peripheral glucose uptake by skeletal muscle and fat ...
US sales of Humalog in Q3 were nearly $415 million ... The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin ...
Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...
Humalog insulin is fast-acting insulin used to treat high blood sugar. According to the highlights of prescribing information from the drug’s manufacturer, Humalog insulin is intended to be ...
Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results